Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?

I. Sequeiros, N. Jarad (Bristol, United Kingdom)

Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session: Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session type: Poster Discussion
Number: 3611

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Sequeiros, N. Jarad (Bristol, United Kingdom). Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home?. Eur Respir J 2013; 42: Suppl. 57, 3611

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Home care and benefit in days of hospitalization, cost and quality of life for children with cystic fibrosis
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Quality of life of paediatric patients with cystic fibrosis and their caregivers
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Quality of life in children with cystic fibrosis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 342s
Year: 2002

Quality of life and health utility in patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis
Source: Eur Respir J 2013; 42: 371-379
Year: 2013



The physical and psychological needs of patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013

Quality of life of idiopathic pulmonary fibrosis patients
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Quality of life in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


LATE-BREAKING ABSTRACT: Health-related quality of life of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014


Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019
Year: 2019



The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

One-year change in health status and outcomes in chronic obstructive pulmonary disease
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014